Answers are grounded in this paper and cite their sources.
Simultaneous kidney-pancreas transplantation remains the gold standard treatment for patients with type I diabetes and end-stage renal disease. The evolution of donor demographics requires the use of marginal donor organs including donors with extended criteria and donation after circulatory death; donor organs which are particularly sensitive to ischemia-reperfusion injury. Ex-situ normothermic perfusion (NP) is currently established in other solid organs to preserve, assess and rejuvenate donor grafts prior to transplantation. We describe our NP system based on extracorporeal machine oxygenation as a reproducible and affordable strategy to enable pre-clinical experiments in both small animal and human grafts to enable ex-situ assessment. Our NP system is established using modified paediatric extracorporeal machine oxygenation system and using low circuit perfusate volumes to allow prolonged perfusions. This system has reliably supported pancreas grafts for 6 hours maintaining normal macroscopic appearances and characteristics in human (n = 3), porcine (n = 8) and primate non-human pancreases (n = 2). This system mimics the early reperfusion period in transplantation however is readily adaptable to investigate other research objectives in ex-situ pancreas studies.
No takes yet. Share an insight, caveat, or question.
Mesnard et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: